Recommended by the US Committee on Tactical Combat Casualty Care (CoTCCC) and is used by NATO forces and first responder units around the world.
CELOX™ Gauze is designed to help stop bleeding from emergency life-threatening injuries.
Independent comparative tests in the form of a meta-analysis reported a statistically significant improvement in survival with CELOX™
Gauze, compared to alternative agents.
- Published success in the field.
- Successfully stops leakage.
- CELOX™ gauze was associated with a significantly reduced amount of blood loss after treatment.
- Can be used on patients on anticoagulant therapy or patient with trauma induced coagulopathy.
- Improved survival.
CELOX™ stops severe traumatic bleeding
In a meta-analysis within a combat setting, where minimising treatment time was highly desirable, CELOX™ Gauze outperformed the other haemostatic agents tested, and was the only one to demonstrate a statistically significant improvement in survival, including in the more severely injured.
Of 3,792 cases, a haemostatic dressing was applied in 317 (either CELOX™, Hemcon or QuikClot). When comparing patients who had a haemostatic dressing applied versus no haemostatic agent, there was a 7% improvement in survival. CELOX™ was the only individual haemostatic dressing that was associated with a statistically significant improvement in survival, which was most apparent in the more severely injured (NISS 36–75).
